Author
Listed:
- Sergio Fabián Mosquera-Restrepo
(Faculty of Medicine, University Research Headquarters (SIU), University of Antioquia (UdeA))
- Sophie Zuberogoïtia
(University of Toulouse, CNRS, University of Toulouse III-Paul Sabatier)
- Lucie Gouxette
(University of Toulouse, CNRS, University of Toulouse III-Paul Sabatier)
- Emilie Layre
(University of Toulouse, CNRS, University of Toulouse III-Paul Sabatier)
- Martine Gilleron
(University of Toulouse, CNRS, University of Toulouse III-Paul Sabatier)
- Alexandre Stella
(University of Toulouse, CNRS, University of Toulouse III-Paul Sabatier)
- David Rengel
(University of Toulouse, CNRS, University of Toulouse III-Paul Sabatier)
- Odile Burlet-Schiltz
(University of Toulouse, CNRS, University of Toulouse III-Paul Sabatier)
- Ana Cecilia Caro
(Faculty of Exact and Natural Sciences. University of Antioquia (UdeA))
- Luis F. Garcia
(Faculty of Medicine, University Research Headquarters (SIU), University of Antioquia (UdeA))
- César Segura
(University of Antioquia (UdeA))
- Carlos Alberto Peláez Jaramillo
(Faculty of Exact and Natural Sciences. University of Antioquia (UdeA))
- Mauricio Rojas
(Faculty of Medicine, University Research Headquarters (SIU), University of Antioquia (UdeA)
University Research Headquarters (SIU), University of Antioquia, UdeA)
- Jérôme Nigou
(University of Toulouse, CNRS, University of Toulouse III-Paul Sabatier)
Abstract
An estimated one-third of tuberculosis (TB) cases go undiagnosed or unreported. Sputum samples, widely used for TB diagnosis, are inefficient at detecting infection in children and paucibacillary patients. Indeed, developing point-of-care biomarker-based diagnostics that are not sputum-based is a major priority for the WHO. Here, in a proof-of-concept study, we tested whether pulmonary TB can be detected by analyzing patient exhaled breath condensate (EBC) samples. We find that the presence of Mycobacterium tuberculosis (Mtb)-specific lipids, lipoarabinomannan lipoglycan, and proteins in EBCs can efficiently differentiate baseline TB patients from controls. We used EBCs to track the longitudinal effects of antibiotic treatment in pediatric TB patients. In addition, Mtb lipoarabinomannan and lipids were structurally distinct in EBCs compared to ex vivo cultured bacteria, revealing specific metabolic and biochemical states of Mtb in the human lung. This provides essential information for the rational development or improvement of diagnostic antibodies, vaccines and therapeutic drugs. Our data collectively indicate that EBC analysis can potentially facilitate clinical diagnosis of TB across patient populations and monitor treatment efficacy. This affordable, rapid and non-invasive approach seems superior to sputum assays and has the potential to be implemented at point-of-care.
Suggested Citation
Sergio Fabián Mosquera-Restrepo & Sophie Zuberogoïtia & Lucie Gouxette & Emilie Layre & Martine Gilleron & Alexandre Stella & David Rengel & Odile Burlet-Schiltz & Ana Cecilia Caro & Luis F. Garcia & , 2022.
"A Mycobacterium tuberculosis fingerprint in human breath allows tuberculosis detection,"
Nature Communications, Nature, vol. 13(1), pages 1-15, December.
Handle:
RePEc:nat:natcom:v:13:y:2022:i:1:d:10.1038_s41467-022-35453-5
DOI: 10.1038/s41467-022-35453-5
Download full text from publisher
Most related items
These are the items that most often cite the same works as this one and are cited by the same works as this one.
- Xiaocui Ling & Xiao Liu & Kun Wang & Minhao Guo & Yanzhe Ou & Danting Li & Yulin Xiang & Jiachen Zheng & Lihua Hu & Hongyun Zhang & Weihui Li, 2024.
"Lsr2 acts as a cyclic di-GMP receptor that promotes keto-mycolic acid synthesis and biofilm formation in mycobacteria,"
Nature Communications, Nature, vol. 15(1), pages 1-14, December.
- John Jairo Aguilera-Correa & Yara Tasrini & Miguel Gisbert-Garzarán & Aude Boulay & Tamara Carvalho & Fabien P. Blanchet & María Vallet-Regí & Laurent Kremer, 2025.
"In vivo antimicrobial activity of engineered mesoporous silica nanoparticles targeting intracellular mycobacteria,"
Nature Communications, Nature, vol. 16(1), pages 1-17, December.
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:13:y:2022:i:1:d:10.1038_s41467-022-35453-5. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.